
Six-month response to anti-TNF drugs in axial spondylarthropathy according to the fulfillment or not of New-York criteria for ankylosing spondylitis or French recommendations for anti-TNF use. A “real life” retrospective study on 175 patients
Keywords: ضد TNF; Axial; Spondylarthropathy; Ankylosing spondylitis; Anti-TNF; ASAS; Guidelines; Outcome; PASS; Undifferentiated; BASDAI